Caas Capital Management LP Viking Therapeutics, Inc. Transaction History
Caas Capital Management LP
- $552 Million
- Q4 2024
A detailed history of Caas Capital Management LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Caas Capital Management LP holds 17,207 shares of VKTX stock, worth $556,130. This represents 0.13% of its overall portfolio holdings.
Number of Shares
17,207
Previous 17,207
-0.0%
Holding current value
$556,130
Previous $1.09 Million
36.46%
% of portfolio
0.13%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
462Shares Held
64.7MCall Options Held
5.76MPut Options Held
3.4M-
Vanguard Group Inc Valley Forge, PA10.2MShares$329 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$195 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$151 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$68.4 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$60.6 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.48B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...